Fresenius Medical Care recognized for the best annual report among the Dax 30 companies
September 06, 2007Fresenius Medical Care’s 2006 annual report took top honors among the Dax 30 companies in a yearly competition held by the German ”manager magazin”. For the 13th time, the business journal rated the annual reports of the 200 most important publicly traded European companies according to content, language and design as well as the efficiency of financial reporting. The judges praised the language and design of Fresenius Medical Care’s annual report as well as the risk and outlook reports. Overall, the world’s leading dialysis Company received 81.46 points out of a possible 100, moving to the pole position after placing eighth last year.
“We are very pleased to receive this distinguished award. The annual report is a vital tool to communicate to our shareholders and other stakeholders. The annual report highlights the accomplishments of our employees and in a comprehensive and transparent way informs all stakeholders about the growth dynamics of our Company. I am particularly proud of the fact that preparing the annual report is an internal Investor Relations project, and many employees around the world contribute to the content,” said Dr. Ben Lipps, Chief Executive Officer and Chairman of the Management Board of Fresenius Medical Care.
The content and visual design concept of the 2006 annual report is not limited to only presenting services, products and earnings. The annual report also clearly demonstrates to readers how innovative medical devices and therapies that include the best-possible care help people with chronic kidney failure enjoy a high quality of life. Using the common headline “In Touch with Life,” articles in the report illuminate the work of a researcher, a plant manager and a Fresenius Medical Care nurse as well as the day-to-day life of two dialysis patients in Poland and the United States.
The 2006 annual report from Fresenius Medical Care is available as an online version or PDF file on the Internet at www.fmc-ag.com (Investor Relations > Publications), where a printed version can also be ordered.
In June 2007, Fresenius Medical Care was also recognized by the German business magazine “Capital” and the German Society of Investment Professionals (Deutschen Vereinigung für Finanzanalyse und Asset Management or DVFA) for having the best investor relations activities among the Dax companies.
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,500,000 individuals worldwide. Through its network of 2,209 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 171,687 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
top